The new rule was contained within a larger proposal to ensure contraceptive coverage in the face of Republican attacks.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

(HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and ... Generic TDF/FTC reached the highest monthly share of users among all medications from December 2021 to December ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...

Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

mostly tied to patients failing to take HIV medications consistently, and in all cases returned to very low or undetectable levels. “This demonstrates the safety and the fantastic outcomes that we’re ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...